The National Breast Cancer Coalition (NBCC) mourns the loss of Dr. Susan Love, who died on July 2, 2023, after […]
“Changes to FDA warnings and labeling should be grounded in rigorous, contemporary evidence—not post-hoc or subgroup re-analyses of older trials. ”
“As a breast cancer survivor, [Visco] turned pain into purpose, changed the landscape of breast cancer advocacy, and has become a powerful symbol of hope for the nation.”
Nicole Levins, communications director
nlevins@stopbreastcancer.org
The National Breast Cancer Coalition (NBCC) mourns the loss of Dr. Susan Love, who died on July 2, 2023, after […]
NBCC Grassroots Advocates Secure Key Bipartisan Supporters for Metastatic Breast Cancer Access to Care Act NBCC grassroots leaders continue to […]
FDA Draft Guidance for Study Designs to Support Accelerated Approval: “The Bar Is Too Low” On March 27, the Food […]
We should not accept anything less than an approval process that results in drugs that improve or extend lives. On […]
On May 26, the National Breast Cancer Coalition (NBCC) submitted public comments on proposed draft guidance from the U.S. Food […]
